Arrowstreet Capital’s MacroGenics MGNX Stock Holding History

Arrowstreet Capital’s Portfolio MGNX Stock Details MGNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$52.8K	Buy	+11,428	New	+$43.2K	﹤0.01%	1882
2024 Q1	–	Sell	-156,493	Closed	-$1.5M	–	1720
2023 Q4	$1.5M	Buy	+156,493	New	+$1.08M	﹤0.01%	1022
2021 Q2	–	Sell	-124,156	Closed	-$3.95M	–	2090
2021 Q1	$3.95M	Sell	124,156 -145,172	-54%	-$3.53M	0.01%	1280
2020 Q4	$6.16M	Buy	269,328 +88,670	+49%	+$2.04M	0.01%	1111
2020 Q3	$4.55M	Sell	180,658 -217,680	-55%	-$5.94M	0.01%	1180
2020 Q2	$11.1M	Buy	398,338 +347,538	+684%	+$6.04M	0.02%	736
2020 Q1	$296K	Buy	+50,800	New	+$461K	﹤0.01%	1650
2019 Q2	–	Sell	-143,385	Closed	-$2.58M	–	1575
2019 Q1	$2.58M	Buy	143,385 +4,695	+3%	+$81.2K	0.01%	1024
2018 Q4	$1.76M	Buy	138,690 +115,027	+486%	+$1.93M	﹤0.01%	827
2018 Q3	$507K	Buy	+23,663	New	+$504K	﹤0.01%	898
2017 Q2	–	Sell	-24,528	Closed	-$456K	–	1224
2017 Q1	$456K	Buy	+24,528	New	+$473K	﹤0.01%	1107
2016 Q4	–	Sell	-94,468	Closed	-$2.83M	–	2196
2016 Q3	$2.83M	Buy	+94,468	New	+$2.81M	0.01%	829

Other funds holding MGNX

Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return

Arrowstreet Capital's MGNX Position: Q2 2026 in Review

Arrowstreet Capital opened a new position in MacroGenics (MGNX) in Q2 2026: 11,428 shares worth $52.8K. The stake represents ﹤0.01% of the portfolio and ranks #1882 among its holdings. This is a return to the name: Arrowstreet Capital previously reported a position in MGNX as recently as Q4 2023.

Arrowstreet Capital first reported a position in MGNX in Q3 2016 and has held it in 12 quarters since. The position peaked at $11.1M in Q2 2020. 122 funds tracked by Wall St. Rank hold MGNX as of Q2 2026.

Arrowstreet Capital held 11,428 shares of MacroGenics worth $52.8K as of Q2 2026.
MacroGenics was a new Arrowstreet Capital position in Q2 2026.
MacroGenics made up ﹤0.01% of Arrowstreet Capital's portfolio in Q2 2026, its #1882 holding.
Arrowstreet Capital first reported a position in MacroGenics in Q3 2016 and has held it in 12 quarters since.
Arrowstreet Capital's MacroGenics position peaked at $11.1M in Q2 2020.
122 funds tracked by Wall St. Rank held MacroGenics as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.